Congratulations to Transcera Inc. and Thymmune Therapeutics for receiving our two golden tickets for LabCentral! I want to thank all of the finalists who pitched at our virtual event, all cutting edge start-ups with a bright future ahead that I am excited to follow and be in touch with.
After a nervy morning in mid-October spent pitching to hundreds of potential investors over Zoom, a group of startup entrepreneurs reconvened at the Ameswell Hotel in Mountain View, California.
Boston, MA – Now in its 12th year, MassChallenge, the global network for innovators, awarded 39 equity-free cash and investment prizes to 36 startups from the 2021 early-stage programs in Austin, Boston, Houston, and Rhode Island.
Transcera is a biotech company transforming the treatment of chronic disease through a new approach to biologic medicine.
Subscribe to our newsletter to get the latest updates